PharmaBoardroom

Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio…

Katinka Zinnemers, managing director of Abacus Medicine, highlights the company's mission to increase access to medicines for all patients and its…

Ingrid Šmerdová, General Manager of Adamed in the Czech Republic and Slovakia, shares her thoughts about the role their future product pipeline will…

Gergely Jánoki CEO of Medi-Radiopharma shares his insights on the activities of the company, the trends in the radiopharmaceutical industry while…

Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving…

István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning…

Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide…

Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its…

Li Qing of Illumina China discusses his recent move to the company, the strategic significance of the China market to Illumina global, and the…

Mengchu Wu, CEO of Health Genetech, introduces the innovative precision medicine company as it prepares to transition from a research-positioned…

Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory…

The WHO has published its most recent edition of the Essential Medicines List in July 2019. On the list are 28 new medicines for adults, making a…